Literature DB >> 31622217

Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Diagnosis and Treatment of Breast, Ovarian and Cervical Cancers.

Sekhar Talluri1, Rama R Malla2.   

Abstract

BACKGROUND: The potential of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) as theranostic agents for cancer has been investigated extensively. SPIONS can be utilized for diagnostic imaging, drug delivery as well as for therapeutic applications. SPIONS are of particular interest because of their potential for non-invasive diagnosis and non-invasive therapeutic applications. This article is a review of in vivo and clinical studies of SPIONs for diagnosis and treatment of breast, ovarian and cervical cancer. The current limitations of this technology with relation to clinical therapeutic applications and the potential to overcome these limitations are also discussed.
METHODS: NCBI Pubmed was searched for relevant documents by using keyword and MESH based search. The following keyword combinations were used: 'breast cancer' and SPION, 'ovarian cancer' and SPION, and 'cervical cancer' and SPION. The resulting list was manually scanned for the studies involving clinical and in vivo studies.
RESULTS: The 29 most relevant publications were identified and reviewed.
CONCLUSION: Although numerous in vitro and in vivo studies have demonstrated the safety and effectiveness of the use of SPIONs for both diagnostic and therapeutic applications, there is relatively little progress towards translation to clinical applications involving breast, ovarian and cervical cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  MRI; SPION; breast cancer; cervical cancer; non-invasive imaging; ovarian cancer; theranostics.

Mesh:

Substances:

Year:  2019        PMID: 31622217     DOI: 10.2174/1389200220666191016124958

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  7 in total

1.  Systematic Identification of Genomic Markers for Guiding Iron Oxide Nanoparticles in Cervical Cancer Based on Translational Bioinformatics.

Authors:  Haohan Zhou; Jiayi Tian; Hongyu Sun; Jiaying Fu; Nan Lin; Danni Yuan; Li Zhou; Meihui Xia; Liankun Sun
Journal:  Int J Nanomedicine       Date:  2022-06-29

Review 2.  Nanomagnet-facilitated pharmaco-compatibility for cancer diagnostics: Underlying risks and the emergence of ultrasmall nanomagnets.

Authors:  Divya S Parimi; Yamini Gupta; Sreekar Marpu; Chandra S Bhatt; Tharun K Bollu; Anil K Suresh
Journal:  J Pharm Anal       Date:  2021-11-10

Review 3.  Update on the Use of Nanocarriers and Drug Delivery Systems and Future Directions in Cervical Cancer.

Authors:  Loredana Maria Himiniuc; Bogdan Florin Toma; Razvan Popovici; Ana Maria Grigore; Alexandru Hamod; Constantin Volovat; Simona Volovat; Irina Nica; Decebal Vasincu; Maricel Agop; Mihaela Tirnovanu; Lacramioara Ochiuz; Anca Negura; Mihaela Grigore
Journal:  J Immunol Res       Date:  2022-05-04       Impact factor: 4.493

4.  Co0 superparamagnetic nanoparticles stabilized by an organic layer coating with antimicrobial activity.

Authors:  Paula A Santana; Carolina A Castillo; Sebastián A Michea; Diego Venegas-Yazigi; Verónica Paredes-García
Journal:  RSC Adv       Date:  2020-09-18       Impact factor: 4.036

Review 5.  The Proteolytic Landscape of Ovarian Cancer: Applications in Nanomedicine.

Authors:  Cailin O'Connell; Sabrina VandenHeuvel; Aparna Kamat; Shreya Raghavan; Biana Godin
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 6.  Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives.

Authors:  María Gabriela Montiel Schneider; María Julia Martín; Jessica Otarola; Ekaterina Vakarelska; Vasil Simeonov; Verónica Lassalle; Miroslava Nedyalkova
Journal:  Pharmaceutics       Date:  2022-01-16       Impact factor: 6.321

Review 7.  A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics.

Authors:  Pedro Farinha; João M P Coelho; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Nanomaterials (Basel)       Date:  2021-12-17       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.